Results 301 to 310 of about 237,113 (353)

Dihydrogeodin from <i>Fennellia flavipes</i> Modulates Platelet Aggregation via Downregulation of Calcium Signaling, αIIbβ₃ Integrins, MAPK, and PI3K/Akt Pathways. [PDF]

Mar Drugs
Akram AW, Choi DC, Chae HK, Kim SD, Kwak D, Yun BS, Rhee MH.   +6 more
europepmc   +1 more source

Material strengths of shear-induced platelet aggregation clots and coagulation clots. [PDF]

Sci Rep
Kim DA, Ku DN.
europepmc   +1 more source

Bioanalytical method development, in-vivo pharmacokinetic evaluation, ex-vivo platelet aggregation inhibition activity of a novel solid dispersion formulation of ticagrelor. [PDF]

Front Med Technol
Srivastava A, Bedi S, Mehata AK, Pawde DM, Hatware KV, Khan MA, Muthu MS, Bhandari U.   +7 more
europepmc   +1 more source

Effects of nerve growth decoction on platelet aggregation and thrombosis formation

, 2007
Fei Ding
openalex   +1 more source

[Platelet aggregation and platelet antiaggregants].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1988
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Shear-induced platelet aggregation

The Lancet, 1990
Two platelet mechanisms contribute to haemostasis and thrombosis. (1) Compounds such as thrombin activate glycoprotein IIb/IIIa; fibrinogen is the ligand. The cyclooxygenase pathway is involved and so this process is aspirin sensitive. (2) Shearing forces alone activate a different domain on glycoprotein IIb/IIIa; von Willebrand's factor is the ligand.
openaire   +4 more sources

Platelet aggregation by platelet-clumping substance

Thrombosis Research, 1974
Abstract The platelet-clumping substance isolated from rabbit plasma by the authors aggregated washed rabbit platelets, while ADP did not. The presence of AMP or adenosine did not inhibit the appearance of platelet aggregation induced by the clumping substance.
H, Yamazaki, T, Sano, T, Shimamoto, T, Shimamoto   +3 more
openaire   +2 more sources

Platelet aggregation and platelet-inhibiting drugs

Neurochemical Pathology, 1987
Platelet function may cause a progression of central gray matter damage after cerebrospinal hemorrhage or trauma because of the thrombotic occlusion of injured vessels or a vasospasm induced by extravasated blood. It has therefore been suggested that antiplatelet drugs could limit the extent of the neurological lesions produced by a spinal trauma.
openaire   +2 more sources